Clinical Trial

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Study acronym: HSS
Recruiting
View on ClinicalTrials.gov →
Summary
Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-01-27; most recent amendment 2025-04-05.
Status change: Not Yet Recruiting → Recruiting 2022-10-24
Trial Details
NCT Number NCT05216666
Lead Sponsor Sahlgrenska University Hospital
Collaborators: Vastra Gotaland Region
Conditions Hip Osteoarthritis, Muscle Weakness, Muscle Atrophy, Muscle Injury, Arthroplasty Complications
Enrollment 580 participants
Start Date 2022-05-11
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-09